Last reviewed · How we verify
NCT05023954
mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis
trial testing Blood test in Sepsis in 330 participants. Status unknown.
1 April 2022
Quick facts
| Lead sponsor | Cardiff University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 330 |
| Start date | 12 October 2020 |
| Primary completion | 1 April 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Blood test — full drug profile →
Conditions studied
- Sepsis — all drugs for Sepsis →
- Maternal Sepsis — all drugs for Maternal Sepsis →
- Maternal Sepsis During Labor — all drugs for Maternal Sepsis During Labor →
- SIRS — all drugs for SIRS →
Sponsor
Cardiff University
Who can join
Adults 18 to 50, female only, with Sepsis or Maternal Sepsis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective observational cohort study investigating physiological parameters vs biological markers of whole blood in septic and non-septic pregnant woman to predict systemic immune health
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
mSep: investigating physiological and immune-metabolic biomarkers in septic and healthy pregnant women to predict feto-maternal immune health - a prospective observational cohort study protocol.
Sharma S, Zaher S, Rodrigues PRS, Davies LC, et al · · 2022 · cited 1× · PMID 36115679 · DOI 10.1136/bmjopen-2022-066382
Verify or expand the search:
- PubMed search for NCT05023954
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood test
Trials testing the same drug.
- NCT06863974 — High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Im · NA · recruiting
- NCT07078435 — Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis · NA · not yet recruiting
- NCT05370300 — SNAPS Breast Cancer Patient Study Breast Cancer Patients · not yet recruiting
- NCT06820450 — Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis · not yet recruiting
- NCT06999785 — Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperba · NA · recruiting
Other recruiting trials for Sepsis
Currently open trials in the same condition.
- NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
- NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
Other Cardiff University trials
Trials by the same sponsor.
- NCT06587360 — fertiShare Evaluation · NA · recruiting
- NCT06639867 — Sensor-based Physiotherapy Intervention With Virtual Reality · NA · active not recruiting
- NCT05726669 — Self-help Booklets for Depression in Adults With Pulmonary Hypertension. · NA · completed
- NCT05779527 — Mindful Parenting - A Single Case Experimental Design Study · NA · unknown
- NCT04904523 — Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children. · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05023954 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardiff University
- Last refreshed: 27 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05023954.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing